Zhejiang Xinguang Pharmaceutical Co Ltd Total Liabilities
Zhejiang Xinguang Pharmaceutical Co Ltd total liabilities. Based on the latest financial reports, Zhejiang Xinguang Pharmaceutical Co Ltd (300519) has total liabilities worth CN¥65.46 Million CNY (≈ $9.58 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Zhejiang Xinguang Pharmaceutical Co Ltd to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Zhejiang Xinguang Pharmaceutical Co Ltd (2011–2024)
Total liabilities of Zhejiang Xinguang Pharmaceutical Co Ltd from 2011 to 2024. This chart illustrates how Zhejiang Xinguang Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore 300519 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Zhejiang Xinguang Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Zhejiang Xinguang Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hunan Creator Information Technologies Co Ltd Class A
SHE:300730
|
China | CN¥407.64 Million |
|
Firma Oponiarska DĘBICA SA
WAR:DBC
|
Poland | zł883.16 Million |
|
EVN Finance JSC
VN:EVF
|
Vietnam | ₫81.34 Trillion |
|
Esso (Thailand) Public Company Limited
BK:BSRC
|
Thailand | ฿36.69 Billion |
|
Zhejiang Ming Jewelry Co Ltd
SHE:002574
|
China | CN¥3.30 Billion |
|
Hemisphere Properties India Limited
NSE:HEMIPROP
|
India | Rs7.32 Billion |
|
Lowland Investment Co
LSE:LWI
|
UK | £51.86 Million |
|
J.Kumar Infraprojects Limited
NSE:JKIL
|
India | Rs-33.68 Billion |
Liability Composition Analysis (2011–2024)
This chart breaks down Zhejiang Xinguang Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Zhejiang Xinguang Pharmaceutical Co Ltd.
Liquidity & Leverage Metrics
Zhejiang Xinguang Pharmaceutical Co Ltd Total Liabilities Ratios Explained
Zhejiang Xinguang Pharmaceutical Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 13.41 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.08 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.07 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhejiang Xinguang Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhejiang Xinguang Pharmaceutical Co Ltd (2011–2024)
The table below shows the annual total liabilities of Zhejiang Xinguang Pharmaceutical Co Ltd from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥79.25 Million ≈ $11.60 Million |
-8.15% |
| 2023-12-31 | CN¥86.29 Million ≈ $12.63 Million |
-12.72% |
| 2022-12-31 | CN¥98.86 Million ≈ $14.47 Million |
+14.71% |
| 2021-12-31 | CN¥86.19 Million ≈ $12.61 Million |
+35.00% |
| 2020-12-31 | CN¥63.84 Million ≈ $9.34 Million |
+3.94% |
| 2019-12-31 | CN¥61.42 Million ≈ $8.99 Million |
-11.29% |
| 2018-12-31 | CN¥69.24 Million ≈ $10.13 Million |
+0.00% |
| 2017-12-31 | CN¥69.24 Million ≈ $10.13 Million |
+14.47% |
| 2016-12-31 | CN¥60.49 Million ≈ $8.85 Million |
+13.02% |
| 2015-12-31 | CN¥53.52 Million ≈ $7.83 Million |
-1.07% |
| 2014-12-31 | CN¥54.10 Million ≈ $7.92 Million |
+22.14% |
| 2013-12-31 | CN¥44.29 Million ≈ $6.48 Million |
-41.58% |
| 2012-12-31 | CN¥75.82 Million ≈ $11.09 Million |
-34.09% |
| 2011-12-31 | CN¥115.03 Million ≈ $16.83 Million |
-- |
About Zhejiang Xinguang Pharmaceutical Co Ltd
Zhejiang Xinguang Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of Chinese patent medicines, chemical medicines, and health food in China. It offers pharmaceutical products that cover respiratory, digestive, and urinary systems, as well as cardiovascular, cerebrovascular, trauma, and pediatric diseases. The company was incorporated in 1998 and is headquar… Read more